Slaughter and May advised Reckitt Benckiser Group plc on the annual update of its EMTN programme and subsequent issuances thereunder

Slaughter and May advised Reckitt Benckiser Group plc (“Reckitt”) on the update of its £10,000,000,000 Euro Medium Term Note programme (the “Programme”), the establishment of which Slaughter and May advised on in 2023. Under the Programme, Reckitt Benckiser Treasury Services plc has the ability to issue notes guaranteed by Reckitt which are admitted to trading on the Main Market of the London Stock Exchange.

Immediately following the Programme update, Slaughter and May additionally advised Reckitt on the following issuances:

  • EUR 700,000,000 2.625% Fixed Rate Senior Notes due 10 September 2028;
  • GBP 250,000,000 4.875% Fixed Rate Senior Notes due 10 September 2031; and
  • EUR 650,000,000 3.500% Fixed Rate Senior Notes due 10 September 2034.

Reckitt is the company behind some of the world's most recognisable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more.

Financing
Kevin Howes Partner
Adriana Simpson Associate
Deirdre Healy Associate
Jessica Marshall Associate

Meher Malik / Trainee, Angus White / Trainee

Tax
Mike Lane Partner
Lauren Biggs Associate